FACTOR VIII FORMULATIONS
A Factor VIII (FVIII) composition formulated such that NaCl is not present in the final formulation or is present in trace amounts, which allows for a concomitant reduction in the lyophilization cycle time and increased stability of the lyophilized FVIII. La présente invention concerne une compositi...
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
26.02.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | A Factor VIII (FVIII) composition formulated such that NaCl is not present in the final formulation or is present in trace amounts, which allows for a concomitant reduction in the lyophilization cycle time and increased stability of the lyophilized FVIII.
La présente invention concerne une composition de facteur VIII (FVIII) formulée de manière à ce que pas de NaCl ne soit présent dans la formulation finale ou de manière à ce que le NaCl soit présent en quantités traces, ce qui permet une réduction concomitante de la durée du cycle de lyophilisation et une plus grande stabilité du FVIII lyophilisé. |
|---|---|
| AbstractList | A Factor VIII (FVIII) composition formulated such that NaCl is not present in the final formulation or is present in trace amounts, which allows for a concomitant reduction in the lyophilization cycle time and increased stability of the lyophilized FVIII.
La présente invention concerne une composition de facteur VIII (FVIII) formulée de manière à ce que pas de NaCl ne soit présent dans la formulation finale ou de manière à ce que le NaCl soit présent en quantités traces, ce qui permet une réduction concomitante de la durée du cycle de lyophilisation et une plus grande stabilité du FVIII lyophilisé. |
| Author | PIKAL, MICHAEL JAMEEL, FEROZ BESMAN, MARC TCHESSALOV, SERGUEI BJORNSON, ERIK |
| Author_xml | – fullname: TCHESSALOV, SERGUEI – fullname: PIKAL, MICHAEL – fullname: BESMAN, MARC – fullname: BJORNSON, ERIK – fullname: JAMEEL, FEROZ |
| BookMark | eNrjYmDJy89L5WSQcHN0DvEPUgjz9PRUcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORuYmRsZGFs7GhFUAAEnMIK4 |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | FORMULATION DE FACTEUR VIII |
| ExternalDocumentID | CA2742328C |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CA2742328C3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:00:07 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CA2742328C3 |
| Notes | Application Number: CA20092742328 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190226&DB=EPODOC&CC=CA&NR=2742328C |
| ParticipantIDs | epo_espacenet_CA2742328C |
| PublicationCentury | 2000 |
| PublicationDate | 20190226 |
| PublicationDateYYYYMMDD | 2019-02-26 |
| PublicationDate_xml | – month: 02 year: 2019 text: 20190226 day: 26 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| RelatedCompanies | BAXTER INTERNATIONAL INC UNIVERSITY OF CONNECTICUT |
| RelatedCompanies_xml | – name: UNIVERSITY OF CONNECTICUT – name: BAXTER INTERNATIONAL INC |
| Score | 3.197438 |
| Snippet | A Factor VIII (FVIII) composition formulated such that NaCl is not present in the final formulation or is present in trace amounts, which allows for a... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | FACTOR VIII FORMULATIONS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190226&DB=EPODOC&locale=&CC=CA&NR=2742328C |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LS8NAEB5qFfWmVYnvHCS3ILabJTkESTcJjZimlLT0VrLNFL3UYiP-fWe3iXrpbdmF2RezM9-8FuABkbOSlaVddNGxGTLXLpYqRoy7dOXSIwmoDPrpkA8m7GXmzFrw1uTC6Dqh37o4InHUgvi90u_1-s-IFerYys2jfKeuj-c490OrRsck3UidsMK-H42yMBOWEL4IrOHY33okXbEH-0qJVlX2o2lf5aSs_wuU-AQORkRrVZ1CC1cdOBLNv2sdOExrdzc1a87bnIERByLPxuY0SRKTkFs6ed1mAJ_DfRzlYmDTFPPf3cxF0KyldwFtwvhogOlgFxfYk6RvcUagosAnyT1SVRhfouMVl2DsonK1e-gajtWZ6AxsfgPt6vMLb0mGVvJOb_8HoaRygw |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQIwbDFB5rgfUW4XY0tAdKrSlq1roY5q6abeqXT2Ny5hYEX8fN2uBy25RIjmJI8f-HNsBeEDkLGd5rqddNHSGzNTTZRkjxk068qxPGrB06Achd6fsdW7MG7Cqc2FkndBvWRyRJGpB8l7I-3rz58SyZWzl9jF7p66PFye2bK1Cx6TdyJzQ7KE1Gkd2JDQhLDHQwom1e5E0xQEcPhMglEBpNixzUjb_FYpzCkdjorUuzqCB6za0RP3vWhuOg-q5m5qV5G3PQXEGIo4m6szzPJWQWzD1dxnAF9BxRrFwdZoi-d1NIgb1WnqX0CSMjwqoBnZxgb2M7C3OCFSk-JTxPpkqjC_R6KdXoOyjcr1_qAMtNw78xPfCtxs4Kfkjs7H5LTSLzy-8I31aZPeSFT8gtnVt |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FACTOR+VIII+FORMULATIONS&rft.inventor=TCHESSALOV%2C+SERGUEI&rft.inventor=PIKAL%2C+MICHAEL&rft.inventor=BESMAN%2C+MARC&rft.inventor=BJORNSON%2C+ERIK&rft.inventor=JAMEEL%2C+FEROZ&rft.date=2019-02-26&rft.externalDBID=C&rft.externalDocID=CA2742328C |